Skip to Content

Celldex Therapeutics Inc CLDX

Morningstar Rating
$38.85 +0.12 (0.31%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLDX is trading at a 769% premium.
Price
$39.10
Fair Value
$14.60
Uncertainty
Extreme
1-Star Price
$445.58
5-Star Price
$98.38
Economic Moat
Dngl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLDX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$38.73
Day Range
$38.4339.14
52-Week Range
$22.1052.98
Bid/Ask
$38.71 / $39.06
Market Cap
$2.56 Bil
Volume/Avg
24,203 / 649,894

Key Statistics

Price/Earnings (Normalized)
Price/Sales
328.04
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
160

Comparables

Valuation

Metric
CLDX
PRLD
PSTX
Price/Earnings (Normalized)
Price/Book Value
3.051.623.82
Price/Sales
328.043.75
Price/Cash Flow
Price/Earnings
CLDX
PRLD
PSTX

Financial Strength

Metric
CLDX
PRLD
PSTX
Quick Ratio
31.4411.442.49
Current Ratio
31.7711.642.56
Interest Coverage
−11.22
Quick Ratio
CLDX
PRLD
PSTX

Profitability

Metric
CLDX
PRLD
PSTX
Return on Assets (Normalized)
−23.59%−39.87%−32.17%
Return on Equity (Normalized)
−25.21%−44.79%−76.25%
Return on Invested Capital (Normalized)
−25.04%−43.35%−41.12%
Return on Assets
CLDX
PRLD
PSTX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
RykqfvhjsRkzt$598.1 Bil
Vertex Pharmaceuticals Inc
VRTX
DdbvjgrhRyhtbsf$126.0 Bil
Regeneron Pharmaceuticals Inc
REGN
DrnvdwnKhqxhx$119.6 Bil
Moderna Inc
MRNA
JvvybxcpSbrx$47.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
JpvfrkmNknxqf$30.4 Bil
argenx SE ADR
ARGX
PhhvfpxnFyszt$27.4 Bil
BioNTech SE ADR
BNTX
TbxnpqgjMtqg$20.8 Bil
Biomarin Pharmaceutical Inc
BMRN
ThkhxzvmCpmmp$16.1 Bil
United Therapeutics Corp
UTHR
QxzxbjbbrMbm$14.7 Bil
Incyte Corp
INCY
TrbfntcDjdgnk$12.9 Bil

Sponsor Center